News

2015

HAI/WHO Pharmaceutical Promotion Manual Still Key to Combating Promotion around the World

Three Keys to Curbing Antibiotic Resistance

It’s Time Everyone Knows about Price Inequities in Insulin

HSA4A Signs Partnership Agreement to Address Sexual and Reproductive Health and Rights in East Africa

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

Can the WHO Set the Right Course for Antibiotics?

HAI urges MEPs to support key amendments to TTIP resolution

Successful week of advocacy for HAI delegation at 68th World Health Assembly

The EU-US Trade Deal Could Leave Europeans Sick

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

HAI Launches Innovative Global Study to Improve Access to Insulin

In memory of our Foundation Board Chair, Atze Sybrandy

2014

More work needed on new EMA conflicts of interest policy

Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week

EMA policy on clinical data publication a step ahead, but falls short of true potential

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

Organic farming practices at Highgrove could offer "princely" contribution to curtailing antibiotic resistance

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

Setting precedents: EMA must get clinical trial data policy right to truly act in public interest

HAI Europe calls on EMA's Management Board to stand for data transparency

BMJ statins debate about scientific independence, not rigour

Hoping for "harmony" on global antibiotic resistance strategy

Week in review: Outcomes from WHA67

Progress on access to medicines at WHA67, but WHO funding sorely needed

World Health Assembly: HAI and ARC intervention on antimicrobial resistance, including antibiotic resistance

World Health Assembly 67: HAI and KEI intervention on the Consultative Expert Working Group on Research and Development

World Health Assembly 67: HAI intervention on access to essential medicines

World Health Assembly 67: HAI intervention on the WHO's framework of engagement with non-state actors